Business
Strides Pharma Science Ltd Press Release May 19 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 19, 2023, titled "Strides Puducherry facility receives Establishment Inspection Report (EIR) from USFDA confirming the reclassification of the site from Official Action Indicated (OAI) to Voluntary Action Indicated (VAI)".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 19, 2023, titled "Strides Puducherry facility receives Establishment Inspection Report (EIR) from USFDA confirming the reclassification of the site from Official Action Indicated (OAI) to Voluntary Action Indicated (VAI)". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd